https://www.fortunebusinessinsights.com/animal-health-market-102371
https://www.fortunebusinessinsights.com/animal-health-market-102371
The global animal health market was valued at USD 41.50 billion in 2018 and is expected to
grow to USD 97.54 billion by 2032, registering a CAGR of 6.3% during the forecast period. In
2018, North America held the leading position, contributing 34.02% of the total market
share.
The animal health market is expanding steadily, driven by the rising prevalence of zoonotic
and chronic animal diseases, increasing pet adoption, and the growing demand for livestock-
derived food products. Advances in veterinary diagnostics, vaccines, pharmaceuticals, and
feed additives are enhancing the prevention and treatment of animal health conditions. The
market is further supported by growing awareness of animal welfare, increasing investments
in veterinary research, and the integration of digital technologies in animal care. However,
high treatment costs, regulatory hurdles, and limited access to advanced veterinary services
in certain regions remain key challenges. Despite these barriers, the market continues to
grow as pet ownership rises, livestock health management becomes more critical, and
innovations improve accessibility and effectiveness of veterinary solutions.
Learn more here:
https://www.fortunebusinessinsights.com/animal-health-market-102371
Market Segmentation
The animal health market can be segmented by product type into pharmaceuticals, vaccines,
feed additives, diagnostics, and medical devices. By animal type, the market is categorized
into companion animals and livestock animals. Segmentation by end-user includes
veterinary hospitals and clinics, reference laboratories, point-of-care testing facilities, and
home care settings. Additionally, the market is divided by distribution channels into
veterinary pharmacies, retail outlets, and online platforms.
List Of Key Companies Profiled:
• Zoetis
•
Intervet International B.V.
• Elanco
• Ceva
• Virbac
• Merck & Co., Inc.
• Novartis AG
• Emergent BioSolutions, Inc.
• CSL Limited
•
IDEXX Laboratories, Inc.
• Bayer AG
• Boehringer Ingelheim International GmbH
Market Growth
The animal health market is growing steadily due to the rising prevalence of zoonotic and
chronic animal diseases, increasing pet adoption, and higher demand for livestock products.
Advancements in veterinary diagnostics, vaccines, and therapeutics, along with the
integration of digital health solutions for animals, are further driving market expansion.
Growing awareness about preventive healthcare for pets and livestock is also contributing to
sustained growth.
Market Restraining Factors
The animal health market faces restraints such as high costs of veterinary care and advanced
medical treatments, limited availability of skilled veterinarians in some regions, and
stringent regulatory requirements for drug approvals. Low awareness in emerging
economies about preventive animal healthcare and the prevalence of counterfeit veterinary
medicines also limit market adoption. In livestock health, challenges related to vaccination
compliance and lack of access to advanced diagnostic tools further hinder market growth.
Regional Analysis
North America leads the animal health market, supported by high pet ownership, advanced
veterinary infrastructure, and strong investment in research and development. Europe
shows steady growth driven by regulatory frameworks promoting animal welfare and
preventive healthcare practices. The Asia-Pacific region is emerging as a key growth area due
to increasing livestock farming, rising companion animal ownership, and expanding
healthcare infrastructure. Latin America demonstrates potential growth fueled by livestock
production and exports, while the Middle East and Africa show slower adoption due to
limited veterinary services, lower awareness, and economic constraints.